Latest It Compliance News

Austral Resources Australia Ltd has resumed trading on the ASX following news of a significant capital raising and a strategic investor commitment, signaling renewed confidence in the company’s future.

BPH Global is nearing completion of its novel seaweed-based men’s health supplement, Project Popeye, as it moves toward TGA listing and scientific validation.

NAOS Emerging Opportunities Company Limited has reported a robust half-year profit increase of 103%, alongside a fully franked interim dividend of 2.10 cents per share, reflecting strong portfolio performance and market confidence.

NAOS Ex-50 Opportunities Company Limited has reported a remarkable turnaround with a 261% increase in net profit for the half-year ended December 2025, alongside a fully franked dividend hike and ongoing share buybacks.

Pepper Money Limited reported a record-breaking 2025 financial year, driven by strong growth in originations and assets under management, alongside enhanced ESG reporting and a significant acquisition proposal.

Redox Limited has reported solid half-year results for December 2025, with revenue climbing 6.6% to $673.6 million and profit after tax increasing 8.9% to $43.8 million. The company declared a fully franked interim dividend of 6.5 cents per share, underscoring its financial strength amid dynamic market conditions.

Telstra Group Limited reported solid half-year results for December 2025, with revenue and profit growth underpinning a higher dividend and an expanded share buy-back program. The company’s Connected Future 30 strategy continues to drive operational momentum amid disciplined cost management.

SkyCity Entertainment Group posted a solid half-year profit increase to NZD 12.1 million despite a slight revenue dip, bolstered by a major equity raise and a clean bill on its Adelaide casino licence.

Alcoa of Australia has partnered with the federal government to overhaul the environmental approvals process for its Western Australian mining operations, committing $55 million to conservation efforts and securing operational certainty through 2045.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.

PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.

Aeris Resources has withdrawn aspirational statements about extending mine life at its Tritton and Jaguar operations following its Peel Resources acquisition announcement, urging investors to exercise caution.